Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.71M.
ENTERPRISE VALUE (EV)
$3.71M
Sonoma Pharmaceuticals, Inc.
Market Cap
$5.89M
Enterprise Value (EV)
$3.71M
Market Cap
$5.82M
Enterprise Value (EV)
$3.77M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | $5.89M | $3.71M |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.92M | $701939.00 |
| Lucyd, Inc (LUCY)vs › | $5.83M | $3.42M |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.82M | $3.77M |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.73M | $17.46M |
| enVVeno Medical Corporation (NVNO)vs › | $5.70M | $3.36M |
| Scienture Holdings, Inc. (SCNX)vs › | $6.11M | $8.61M |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | N/A |
| Femasys Inc. (FEMY)vs › | $6.28M | $9.63M |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | $1.97M |
Market Cap
$5.89M
Total Debt
$222000.00
Cash
$2.40M
Enterprise Value
$3.71M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Why use EV instead of Market Cap?
